Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Ogihara

Showing results (101-110 of 337) with videos related to

Pageof 34
Sort By:
American Journal of Hypertension|November 11, 2005
Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptorKazuko Masuo, Tomohiro Katsuya, Hideki Kawaguchi, et al.
The Journal of Gene Medicine|September 11, 2002
Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomesNaruya Tomita, Ryuichi Morishita, Kei Yamamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 10, 2009
Alzheimer disease-associated peptide, amyloid beta40, inhibits vascular regeneration with induction of endothelial autophagyShin-ichiro Hayashi, Naoyuki Sato, Akitsugu Yamamoto, et al.
American Journal of Hypertension|October 10, 2006
Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activationKazuko Masuo, Tomohiro Katsuya, Hideki Kawaguchi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 1, 2007
High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individualsKazuko Masuo, Tomohiro Katsuya, Ken Sugimoto, et al.
International Journal of Molecular Medicine|January 22, 2008
Inhibition of experimental abdominal aortic aneurysm progression by nifedipineNaruya Tomita, Keita Yamasaki, Keiko Izawa, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2010
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trialKazuwa Nakao, Masakazu Hirata, Koji Oba, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 6, 2007
Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertensionTakao Saruta, Toshio Ogihara, Hiroaki Matsuoka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 19, 2008
The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational studyKazuyuki Shimada, Toshiro Fujita, Sadayoshi Ito, et al.
Journal of the American College of Cardiology|November 26, 2002
Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunctionKoichi Yamamoto, Hiroshi Ito, Katsuomi Iwakura, et al.
Pageof 34

Showing results (101-110 of 337) with videos related to

Sort By:
Pageof 34
American Journal of Hypertension|November 11, 2005
Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptorKazuko Masuo, Tomohiro Katsuya, Hideki Kawaguchi, et al.
The Journal of Gene Medicine|September 11, 2002
Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomesNaruya Tomita, Ryuichi Morishita, Kei Yamamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 10, 2009
Alzheimer disease-associated peptide, amyloid beta40, inhibits vascular regeneration with induction of endothelial autophagyShin-ichiro Hayashi, Naoyuki Sato, Akitsugu Yamamoto, et al.
American Journal of Hypertension|October 10, 2006
Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activationKazuko Masuo, Tomohiro Katsuya, Hideki Kawaguchi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 1, 2007
High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individualsKazuko Masuo, Tomohiro Katsuya, Ken Sugimoto, et al.
International Journal of Molecular Medicine|January 22, 2008
Inhibition of experimental abdominal aortic aneurysm progression by nifedipineNaruya Tomita, Keita Yamasaki, Keiko Izawa, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2010
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trialKazuwa Nakao, Masakazu Hirata, Koji Oba, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 6, 2007
Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertensionTakao Saruta, Toshio Ogihara, Hiroaki Matsuoka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 19, 2008
The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational studyKazuyuki Shimada, Toshiro Fujita, Sadayoshi Ito, et al.
Journal of the American College of Cardiology|November 26, 2002
Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunctionKoichi Yamamoto, Hiroshi Ito, Katsuomi Iwakura, et al.
Pageof 34